Mechanisms of podocyte injury and implications for diabetic nephropathy

被引:97
|
作者
Barutta, Federica [1 ]
Bellini, Stefania [1 ]
Gruden, Gabriella [1 ]
机构
[1] Univ Turin, Dept Med Sci, Turin, Italy
关键词
GLYCATION END-PRODUCTS; CANNABINOID RECEPTOR 1; SHARED TRANSCRIPTIONAL NETWORKS; NLRP3 INFLAMMASOME ACTIVATION; GLOMERULAR-FILTRATION-RATE; GLUCAGON-LIKE PEPTIDE-1; KIDNEY-DISEASE; MITOCHONDRIAL DYSFUNCTION; HIGH-GLUCOSE; NEPHROTIC SYNDROME;
D O I
10.1042/CS20210625
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies, including focal segmental glomerulosclerosis (FSGS), obesity-related nephropathy, and diabetic nephropathy (DN). Moreover, albuminuria is an important feature of all chronic kidney diseases (CKDs). Podocytes play a key role in maintaining the permselectivity of the glomerular filtration barrier (GFB) and injury of the podocyte, leading to foot process (FP) effacement and podocyte loss, the unifying underlying mechanism of proteinuric glomerulopathies. The metabolic insult of hyperglycemia is of paramount importance in the pathogenesis of DN, while insults leading to podocyte damage are poorly defined in other proteinuric glomerulopathies. However, shared mechanisms of podocyte damage have been identified. Herein, we will review the role of haemodynamic and oxidative stress, inflammation, lipotoxicity, endocannabinoid (EC) hypertone, and both mitochondrial and autophagic dysfunction in the pathogenesis of the podocyte damage, focussing particularly on their role in the pathogenesis of DN. Gaining a better insight into the mechanisms of podocyte injury may provide novel targets for treatment. Moreover, novel strategies for boosting podocyte repair may open the way to podocyte regenerative medicine. The kidneys filter approximately 180 l of fluids everyday; however, there is no loss of proteins into urine as the glomerular filtration barrier (GFB) retains 99.99% of plasma proteins. Alterations in the GFB result in the development of proteinuria, ranging from albuminuria to massive nephrotic syndrome. Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies, including focal segmental glomerulosclerosis (FSGS), diabetic nephropathy (DN), obesity-related nephropathy, and an important feature of chronic kidney diseases (CKDs). In addition, in patients with CKD, albuminuria is a predictor of progression towards end-stage renal disease (ESRD) and is associated with an increased risk of cardiovascular diseases. Glomerular podocytes are a component of the GFB and podocyte injury is the main cause of albuminuria development. Herein, we will describe patterns of podocyte damage and review underlying mechanisms, focussing particularly on DN.
引用
收藏
页码:493 / 520
页数:28
相关论文
共 50 条
  • [41] Is endothelial dysfunction more deleterious than podocyte injury in diabetic nephropathy? Reply
    Weil, E. Jennifer
    Lemley, Kevin V.
    Myers, Bryan D.
    Nelson, Robert G.
    KIDNEY INTERNATIONAL, 2013, 83 (06) : 1203 - 1203
  • [42] Notch pathway mediates podocyte injury and extracellular matrix synthesis in diabetic nephropathy
    Yao, Min
    Li, Guiying
    Zhang, Tao
    Chi, Yanqing
    Gao, Feng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 1873 - 1881
  • [43] Receptor activator of NF-κB mediates podocyte injury in diabetic nephropathy
    Ke, Guibao
    Chen, Xueqin
    Liao, Ruyi
    Xu, Lixia
    Zhang, Li
    Zhang, Hong
    Kuang, Sujuan
    Du, Yue
    Hu, Juan
    Lian, Zhiwen
    Dou, Caoshuai
    Zhang, Qianmei
    Zhao, Xingchen
    Zhang, Fengxia
    Zhu, Shuangshuang
    Ma, Jianchao
    Li, Zhuo
    Li, Sijia
    He, Chaosheng
    Chen, Xia
    Wen, Yingzhen
    Feng, Zhonglin
    Zheng, Minghao
    Lin, Ting
    Li, Ruizhao
    Li, Bohou
    Dong, Wei
    Chen, Yuanhan
    Wang, Wenjian
    Ye, Zhiming
    Deng, Chunyu
    Xiao, Houqin
    Xiao, Jie
    Liang, Xinling
    Shi, Wei
    Liu, Shuangxin
    KIDNEY INTERNATIONAL, 2021, 100 (02) : 377 - 390
  • [44] The Glomerular Podocyte as a Target of Growth Hormone Action: Implications for the Pathogenesis of Diabetic Nephropathy
    Kumar, P. Anil
    Brosius, Frank C., III
    Menon, Ram K.
    CURRENT DIABETES REVIEWS, 2011, 7 (01) : 50 - 55
  • [45] The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?
    Reddy, Gaddameedi R.
    Kotlyarevska, Kateryna
    Ransom, Richard F.
    Menon, Ram K.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2008, 17 (01): : 32 - 36
  • [46] Inhibition of the lncRNA MIAT prevents podocyte injury and mitotic catastrophe in diabetic nephropathy
    Wang, Ziyang
    Chang, Ying
    Liu, Yue
    Liu, Bing
    Zhen, Junhui
    Li, Xiaobing
    Lin, Jiangong
    Yu, Qun
    Lv, Zhimei
    Wang, Rong
    MOLECULAR THERAPY NUCLEIC ACIDS, 2022, 28 : 136 - 153
  • [47] Catalpol Ameliorates Podocyte Injury by Stabilizing Cytoskeleton and Enhancing Autophagy in Diabetic Nephropathy
    Chen, Yan
    Liu, Qingpu
    Shan, Zengfu
    Mi, Wangyang
    Zhao, Yingying
    Li, Meng
    Wang, Baiyan
    Zheng, Xiaoke
    Feng, Weisheng
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [48] Role of Podocyte Injury in IgA Nephropathy
    Menon, Madhav C.
    Chuang, Peter Y.
    He, John Cijiang
    NEW INSIGHTS INTO GLOMERULONEPHRITIS: PATHOGENESIS AND TREATMENT, 2013, 181 : 41 - 51
  • [49] PRIMARY PODOCYTE INJURY IN IGA NEPHROPATHY
    Grchevska, Ladislava
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 206 - 206
  • [50] Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
    Pei-Pei Su
    Dong-Wei Liu
    Si-Jie Zhou
    Hang Chen
    Xian-Ming Wu
    Zhang-Suo Liu
    Military Medical Research, 2023, (01) : 32 - 44